insights into the role of novel btkis in the treatment landscape of r/r cll
Published 1 month ago • 56 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
1:25
an insight into the future treatment landscape of cll
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:10
next-generation btk inhibitors and their role in the cll treatment landscape
-
1:21
how the concept of fitness in cll has changed with the introduction of novel targeted agents
-
1:51
novel insights into genomic classification and prognosis in aml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
11:11
3mensio ct pre-case planning: tavr with high coronary obstruction risk
-
5:06
evolution of btk inhibitors in cll
-
3:30
point of care testing
-
1:36
an insight into novel modular sirpalpha-based cars
-
1:01
cll resistance mechanisms in the era of novel agents
-
2:37
allo-hsct for cll in the era of novel agents
-
1:52
novel options for patients with cll who relapse after treatment with btk inhibitors and venetoclax
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
2:08
an insight into the current understanding of risk factors for cll
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:50
the value of moving novel agents into the frontline setting in all
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
2:00
associated toxicities of novel therapies for cll
-
1:04
horizon scan of novel and upcoming aml therapies
-
1:42
insights into the limber‐103 trial
-
1:32
novel agent combinations: the future of cll